iodoacetamide has been researched along with Lymphoma in 6 studies
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Recent studies with dimethyldioctadecylammonium bromide (DDA) indicate that it both modifies tumour cells and serves as an immunologic adjuvant in that it enhances protective responses to iodoacetamide-treated lymphoma cells and acts as a potent macrophage activator." | 3.66 | Specific immunoprophylaxis in experimental tumour-host systems. ( Gordon, WC; Prager, MD, 1980) |
| "Treating iodoacetamide (IAD)-modified lymphoma cells with the lipophilic agent dimethyldioctadecylammonium bromide (DDA) increased their immunogenicity as evidenced by the increased capacity of syngeneic, vaccinated hosts to reject subsequent implants of the same lymphoma." | 3.66 | Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent. ( Gordon, WC; Prager, MD, 1978) |
| "Lymphoma L5178Y cells were treated with neuraminidase of Vibrio cholerae, potassium iodine, dithiotreitol (DTT), mercaptoethanol, glutaraldehyde, iodoacetamide, merthiolate, sodium periodate, urea, papaine, trypsine and EDTA, to increase immunoreaction in tumor cells." | 3.65 | [Immunogenicity of L5178Y cells modified by different reagents]. ( Arellano-Blanco, J; Becerril-Meza, G; Fernández-Quintero, P; Gómez-Estrada, H; López-de la Rosa, LM, 1977) |
| "Bacterial endotoxin was administered with iodoacetamide-modified P1798 lymphoma cells to immunize syngenic BALB/cJ mice against this lymphoma to which they are naturally unresponsive." | 3.65 | Endotoxin-stimulated immune response to modified lymphoma cells. ( Allison, JP; Kitto, GB; Ludden, CM; Mandy, WJ; Prager, MD, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prager, MD | 4 |
| Gordon, WC | 3 |
| Weber, G | 1 |
| Jackson, RC | 1 |
| Williams, JC | 1 |
| Goulding, FJ | 1 |
| Eberts, TJ | 1 |
| Gómez-Estrada, H | 1 |
| López-de la Rosa, LM | 1 |
| Becerril-Meza, G | 1 |
| Arellano-Blanco, J | 1 |
| Fernández-Quintero, P | 1 |
| Baechtel, FS | 1 |
| Ludden, CM | 1 |
| Mandy, WJ | 1 |
| Allison, JP | 1 |
| Kitto, GB | 1 |
6 other studies available for iodoacetamide and Lymphoma
| Article | Year |
|---|---|
Specific immunoprophylaxis in experimental tumour-host systems.
Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Iodoacetamide; Lymphoma; Macrophages; Mice; Mic | 1980 |
Enzymatic markers of neoplastic transformation and regulation of purine and pyrimidine metabolism.
Topics: AMP Deaminase; Animals; Cell Transformation, Neoplastic; Humans; Iodoacetamide; Ischemia; Kidney Neo | 1976 |
[Immunogenicity of L5178Y cells modified by different reagents].
Topics: Animals; Antibody Formation; Dithiothreitol; Glutaral; Immunity, Cellular; Iodoacetamide; Lymphoma; | 1977 |
Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent.
Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Female; Graft Rejection; Immunotherapy; Iodoace | 1978 |
Immunogenicity of modified tumor cells in syngenic hosts.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Ascitic Fluid; Asparaginase; Immunity, Cellular | 1976 |
Endotoxin-stimulated immune response to modified lymphoma cells.
Topics: Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Cell Membrane; Endotoxins; Graft Rejection; Iodoa | 1975 |